HMN 2026: How Lab-grown retina gives gene change clue to rare childhood eye condition

A study using tiny retinas grown in a lab has revealed how subtle changes in a key growth-controlling protein can lead to a condition causing serious eye defects from birth. The findings, published in the journal Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, shed new light on ocular coloboma, a rare congenital eye condition affecting about 1 in 5,000 births and responsible for roughly 10% of childhood blindness. Coloboma arises when a structure in the developing eye, the optic fissure, fails to close properly and often co-occurs with other tissue-fusion problems such as cleft lip and/or palate.

The study was led by University of Manchester scientists in collaboration with researchers from Manchester University NHS Foundation Trust and the Greenwood Genetic Center in the United States.

The research focused on YAP1, a protein that helps guide how organs form and how tissues stay healthy. YAP1 acts like a switch inside cells, helping them decide when to grow, change, or survive based on signals they receive.

Although changes in YAP1 have been linked to coloboma, why some people with these changes develop severe eye defects while others remain unaffected has not been well understood. To address this question, the team tested the different variants and compared their effects.

To understand the consequences of YAP1’s inactivity during eye development, the researchers studied human retinal organoids—lab-grown miniature versions of the developing human retina grown in the lab. When they reduced the activity of YAP1, they saw effects on how early retinal cells grow and develop.

Disrupting YAP1, they found, reduced the activity of genes needed for early retinal cells to grow and maintain their identity. As a result, the cells developed more slowly, providing a potential explanation for how eye formation goes wrong.

The study also showed that not all YAP1 variants have the same effect. Using computer modeling alongside experimental data, the researchers found that the precise location of each genetic change determines how strongly it disrupts YAP1 function.

This helps explain why coloboma can vary so widely between individuals, even among those carrying changes in the same gene.

Coloboma has been linked to disease causing variants in more than 40 genes, but thanks to the study, YAP1 is now identified as an important contributor.

“These findings give us a much clearer picture of how small genetic changes can have major effects during eye development,” said the lead author Dr. Cerys Manning from The University of Manchester. “By pinpointing how each variant disrupts YAP1’s function, we can better interpret genetic results in patients and move closer to ways of supporting healthy eye formation.

“By combining stem-cell models with detailed genetic testing, we’re finally beginning to understand how tiny changes in YAP1 can have such a big impact on how the eye forms. This work brings us a step closer to explaining why some children develop coloboma.

“Though retinal organoids cannot currently replace the use of animal models, this study shows how they can help us meet our ethical and legal obligations to replace, reduce and refine the use of animals in research wherever feasible.

“It also offers a new framework for understanding how likely YAP1 mutations are to cause disease in children with unexplained eye conditions.”

The content is provided for information purposes only.